StonvexLoading…
StonvexStonvexStonvexCore line items from MREO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $500.00K | $500.00K | $500.00K | $0.00 |
Operating Income | $-40.11M | $-31.72M | $-21.70M | $-47.36M |
Net Income | $-41.88M | $-34.53M | $-14.62M | $-43.25M |
EPS (Diluted) | $-0.05 | $-0.04 | $-0.03 | $-0.06 |
Total Assets | $45.92M | $53.60M | $62.63M | $76.39M |
Total Liabilities | $5.00M | $7.00M | $8.45M | $15.42M |
Cash & Equivalents | $40.99M | $48.70M | $56.13M | $69.80M |
Free Cash Flow OCF − CapEx | $-30.99M | $-23.31M | $-16.00M | $-32.83M |
Shares Outstanding | 797.12M | 796.02M | 794.02M | 739.62M |